Gonorrhea in California Gonorrhea Control in Region IX: Optimizing Strategies to Reduce Morbidity...
-
Upload
allen-lawrence -
Category
Documents
-
view
213 -
download
1
Transcript of Gonorrhea in California Gonorrhea Control in Region IX: Optimizing Strategies to Reduce Morbidity...
Gonorrhea in California
Gonorrhea Control in Region IX: Optimizing Strategies to Reduce MorbidityPhoenix, AZ
January 14, 2010
Michael C. Samuel, Dr.P.H.Chief, Surveillance and Epidemiology Section, STD Control Brach
Gail Bolan, M.D.Chief, STD Control Branch
Division of Communicable Disease ControlCenter for Infectious Diseases, California Department of Public Health
0
50
100
150
200
250
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Year
Ra
te p
er
10
0,0
00
po
pu
lati
on
Gonorrhea, Rates by Gender, California, 1990–2009
Gonorrhea Rates, 1913-2009, California
0
100
200
300
400
500
600
1913
1920
1930
1940
1950
1960
1970
1980
1990
2000
2009
YearR
ate
pe
r 1
00
,00
0
CA DPH STD Control Branch (rev 1/2010)
Female
Male
GC Outbreaks in California
• Butte, 2003, 95 cases– low SES, racial mixing, meth, incarceration, casinos?
• Central CA, 2004/5, 700 cases– meth, incarceration
• Lake County, 30+ cases– 2009; core social network?
Distribution of Population and Cases by Race/EthnicityCalifornia, 2008
Native American/Alaskan Native
Asian/Pacific Islander
African American
Hispanic/Latino
White
Native American/Alaskan Native
Asian/Pacific Islander
African American
Hispanic/Latino
White
Note:Charts exclude cases of multi and unknown race/ethnicity which accounted for 33.1% of total gonorrhea cases, 35.1% of total chlamydia cases, 4.7% of total P&S syphilis cases, and 0.4% of living AIDS cases.
Source:California Department of Public Health, STD Control Branch and Office of AIDS
Gonorrhea, Female Rates by Race/Ethnicity and Age Group California, 2008
0
200
400
600
800
1,000
1,200
1,400
1,600
Ra
te p
er
10
0,0
00
10 - 14 15 - 19 20 - 24 25 - 29 30 - 34 35 - 44 45+
White
Hispanic
Black
Age Group
24 times white rate
CA DPH STD Control Branch (rev 7/2009)
0.7
0.10
3.1
2.3
1.6
0.40.2 0.1
0.4 0.30.2
0
1
2
3
4
15-19 20-24 25-29
Pe
rce
nt
Po
sit
ive
Asian/Pacific Islander African American Latina White
Gonorrhea Prevalence Monitoring, Percent Positive for Female Family Planning Quest Clients by Age Group & Race/Ethnicity,
California, 2007
Note:Native American/Alaskan Natives were excluded due to low test volume.
Source:California Department of Public Health, STD Control Branch; Quest/Unilab at San Jose, Sacramento and West Hills/Tarzana
0
100
200
300
400
500
600
700
800
900
<10% 10-<20% 20-<30% >30%
Census Tract Poverty Category
Ra
te p
er
10
0,0
00
po
p. p
er
yea
r Asian White Hispanic African American
Gonorrhea Rates by Case Race/Ethnicity and Poverty Category of Case Census Tract (percent residents living below the federal poverty line)
California, 2004-2006
Note: Rates calculated by weighting the number of cases to account for geocodable cases lacking race/ethnicity data.
Gonococcal Isolate Surveillance Project (GISP), Percent of Neisseria Gonorrhoeae Isolates with Decreased Susceptibility or Resistance to
Ciprofloxacin in Five California STD Clinics, 1990–2008
Note: Resistant isolates have MICs ≥ 1 μg ciprofloxacin/mL. Isolates with decreased susceptibility have MICs of 0.125 – 0.5 μg ciprofloxacin/mL.
STD Clinic Sites: Long Beach (ended participation in 2007), Los Angeles (added in 2003), Orange,San Diego, San Francisco
0
5
10
15
20
25
30
35
40
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Year
Pe
rce
nt
of
Iso
late
s
Resistant Decreased Susceptibility
CA DPH STD Control Branch (rev 7/2009)
GISP Alert Value and Resistant Isolates, CA GISP Data, 1987 - 2009
* Cefixime was dropped from the testing panel at the beginning of 2007 and reinstated in 2009** Cefpodoxime was introduced in 2009; 2009 data not complete *** Can be more than one per isolate
0
10
20
30
40
50
60
70
80
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007*
2008 2009**
Year
Nu
mb
er o
f Is
ola
tes*
**
AZITHROMYCIN HIGH RESISTANT (>= 8.0)
AZITHROMYCIN LOW RESISTANT (>= 1.0)
CEFPODOXIME RESISTANT (>= 1.0)
CEFPODOXIME ALERT (>= .250)
CEFIXIME ALERT (>= .250)
CEFTRIAXONE ALERT (>= .125)
Sexual Orientation by RegionCalifornia Gonorrhea Surveillance Data, 2008
REGION MSMMale
Heterosexual Female
Northern CA 10.1% 30.0% 59.9%
Bay Area (excluding SF) 16.7% 29.8% 53.5%
San Francisco 75.9% 11.0% 13.0%
Central CA 11.9% 38.6% 49.4%
Southern CA (excluding LA) 24.1% 28.1% 47.8%
Los Angeles 26.4% 26.0% 47.5%
TOTAL 26.2% 27.0% 46.8%
Assumed proportion of male pop MSMWhite Black Hispanic0.05 0.05 0.05
MSMMale-HetFemale
MSM ratio to whiteMale-Het ratio to white
0.0
50.0
100.0
150.0
200.0
250.0
MSM Male-Het Female
est
iam
ted
ra
te p
er
10
0,0
0 p
op
White Black Hispanic
Assumed proportion of male pop MSMWhite Black Hispanic0.10 0.15 0.15
MSMMale-HetFemale
MSM ratio to whiteMale-Het ratio to white
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
MSM Male-Het Female
estia
mte
d ra
te p
er 1
00,0
0 po
p
White Black Hispanic
Selected Risk Characteristics for by Sexual OrientationCalifornia Gonorrhea Surveillance Data, 2008
Men Who Have Sex With Men
(MSM)
HeterosexualMen
Heterosexual Women
Internet Use to Meet Sex Partners 43.2% 5.1% 2.7%
CaseIncarcerated 3.4% 23.7% 9.0%
Sex Partner Incarcerated 4.6% 5.2% 22.8%
Methamphetamine Use 7.5% 8.9% 5.5%
Other Analyses
• Other GC Control-Related Data/Reports Available on Request– Re-infection – Matching to HIV/AIDS data– SSuN/CGSS Surveillance Evaluation– CGSS – risk factors– CGSS – appropriate treatment of GC by provider type– GISP MIC trends– Estimates/Projections of GC rates by race/ethnicity and sexual orientation
• Mapping/GIS Work Planned– Race-specific census tract-level maps for all races in addition to blacks– Demographic and risk (if available) characteristics of “hot spot” census
tracts– Plotting key provider location data (including race-specific) on census tract-
level maps
Program Activities
• Evidence-based guidelines– 2006 GC Screening Guidelines– 2005 GC Treatment Guidelines– Developing re-testing guidelines– Developing Ceph-R GC management guidelines
• Quality initiatives to improve GC clinical performance– Use of HMO and Family Pact prevalence data to
alter screening practices – Use of CGSS Surveillance data to improve GC
treatment
Non-Recommended Treatment, by Setting of DiagnosisCalifornia Gonorrhea Surveillance System, Weighted 2008 Data
•San Francisco gonorrhea cases excluded from analysis on setting of diagnosis
3 “Other” setting includes HIV Clinics, Hospital Inpatient, Military/VA, School-based Clinics, and Other
Program Activities
• Outbreak investigation and control– Partner management– Assess networks and venues– GISP “Alert” values
• Program Assessment and Evaluation– Screening (e.g. Family Pact, Juvenile Detention)– EPT (Family Planning Clinics)– Community Resource Assessment
• Racial Disparities– Staff training– Slide Set, Fact Sheet– Trainer Guide
Acknowledgements
CA STD Control Branch:
Surveillance and Epidemiology Section
Disease Intervention and Field Investigation Section
Program Development and Evaluation Section
Health Promotion and Disease Prevention Section
STD Mapping/GIS Working Group
Racial Disparities Working Group
Gonorrhea Control Working Group
Contact:
510-620-3198
510-620-3400
Black & White Gonorrhea Rates and Rate Ratiosby Gender, California, 1990–2008
0.0
200.0
400.0
600.0
800.0
1,000.0
1,200.0
1,400.0
1,600.0
1,800.0
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
rate
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
rate
ratio
Black - Male Black - FemaleWhite - Male White - FemaleBlack:White - Male Black:White - Female
CA DPH STD Control Branch (rev 7/2009)
Note: Race/ethnicity “Not Specified” ranged from 21.1% to 36.1% of cases for males in any given year.
Gonorrhea Rates by Health Jurisdiction & Race/EthnicityCalifornia, 2008
ASIAN/PIAFRICAN
AMERICAN LATINO WHITE
Note:Cases with unspecified race have been redistributed based on the ratio of individual races to total known races.Cases with missing gender have been excluded from the gender-specific redistribution analysis.
Source:California Department of Public Health, STD Control Branch
Rates per 100,000 Population
< 5 cases 0 0.1 - 24.9 25 - 49.9 50 - 99.9 100 - 249.9 250 - 499.9 500 +
Assessing Counties/Census Tracts with High Concentrations of African American GC Cases – California, 2008
Year CENTRACT County Black Cases Black Cases - Weighted Rank2008 600152020 Alameda 0 0 bottom 502008 600153030 Alameda 1 1 bottom 502008 600640050 Alameda 12 21 top 5%
.
.
.2008 600554020 Contra Costa 4 9 next 20%2008 600630011 Butte 0 0 bottom 50
.
.
.
Top 5%Next 20%
(25% cumulative)Next 25%
(50% cumulative)Bottom 50%
(100% cumulative) Total
# of CPA census tracts accounty for cases
8 72 147 4757 4984
Percent including CPA tracts with no cases
0.16% 1.4% 2.9% 95.5% 100.0%
Cumulative Percent 0.16% 1.6% 4.6% 100.0% 100.0%
Assessing Counties/Tracts with High Concentration of African American GC Cases – California, 2008
>0 >=5 >=10
# CPA tracts BlackCatZBESTYR County 1-Top 5 2-Next 20 3-Next 25 4-Bottom 50 (blank) Grand Total
2008 Alameda 6 19 40 191 256Amador 1 1Butte 25 25Colusa 1 1Contra Costa 9 10 106 125El Dorado 7 7Fresno 7 113 120Inyo 1 1Kern 8 8 97 113Kings 20 20LA (Long Beach) 2 16 65 83LA (Pasadena) 19 19Riverside 1 2 246 249Sacramento 14 28 193 235San Benito 5 5San Bernardino 2 12 18 172 204San Diego 1 6 380 387Yuba 5 5
Grand Total 8 72 147 2986 3213
Cumulative Proportion of Black & Total Cases Accounted for by Cumulative Proportion of Census Tracts, Gonorrhea, California, 1990–2008
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.00.
00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
Percent of Tracts
Per
cent
of C
ases
All CasesBlack Cases
Cumulative Proportion of Black & Total Cases Accounted for by Cumulative Proportion of Census Tracts, Gonorrhea, California, 1990–2008
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.500.
00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
Percent of Tracts
Per
cent
of C
ases
All CasesBlack Cases
0
100
200
300
10-14 15-19 20-24 25-29 30-34 35-44 45+
Age Group
Ra
te p
er
10
0,0
00
po
pu
lati
on Female Male
Gonorrhea, Rates by Gender and Age Group (in years) California, 2008
Note: Gender “Not Specified” accounted for less than 0.5% of all cases.
CA DPH STD Control Branch (rev 7/2009)
0
100
200
300
400
NativeAmerican/
Alaskan Native
Asian/PacificIslander
Black Latino White
Ra
te p
er
10
0,0
00
po
pu
lati
on
Female Male
Gonorrhea, Rates by Gender and Race/Ethnicity California, 2008
Note: Race/Ethnicity was “Not Specified” for 33.5% of female cases and 32.4% of male cases for thegiven year.
CA DPH STD Control Branch (rev 7/2009)
GISP Cephalosporin Alert Values
• Resistance thresholds not established for cephalosporins• Alert values have been set at:
– Ceftriaxone MIC >= 0.125– Cefixime MIC >= 0.250– Cefpodoxime MIC >= 0.250
• In 2009 to date, 8 isolates have met or exceeded this threshold for cefpodoxime, 4 for cefixime, and 3 for ceftriaxone
• In addition, 5 San Diego isolates have exhibited exceptionally strong resistance to azithromycin (MIC >= 8.0; resistance >= 1.0)
• An enhanced interview protocol has been implemented that includes test-of-cure and re-culture for the index case and testing/treatment of partners
FIX FORMAT